The policy implications of cannabis dependence

Cannabis Dependence: Its Nature, Consequences, and Treatment

Volumn , Issue , 2006, Pages 315-340

  Hall, Wayne ^a   Swift, Wendy ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84926972968     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544248.016     Document Type: Chapter

References (118)

1. Ali, R., Christie, P., Lenton, S., Hawks, D., Sutton, A., et al. (1999). The Social Impacts of the Cannabis Expiation Notice Scheme in South Australia: Summary Report Presented to the Ministerial Council on Drug Strategy (National Drug Strategy Monograph, Vol. 34). Canberra, Australian Capital Territory: Commonwealth Department of Health and Aged Care.
2. Anthony, J. C. (2000). Putting epidemiology and public health in needs assessment: drug dependence and beyond. In G. Andrews, & S. Henderson (Eds.), Unmet need in psychiatry: problems, resources, responses (pp. 302-308). Cambridge, MA: Cambridge University Press.
3. Anthony, J. C., & Helzer, J. E. (1991). Syndromes of drug abuse and dependence. In L. N. Robins, & D. A. Regier (Eds.), Psychiatric disorders in America: the epidemiologic catchment area (pp. 116-154). New York: Free Press.
4. Anthony, J. C., & Petronis, K. R. (1995). Early-onset drug use and risk of later drug problems. Drug and Alcohol Dependence, 40(1), 9-15.
5. Anthony, J. C., Warner, L., & Kessler, R. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology, 2(3), 244-268.
6. Armor, D., Polich, J. M., & Stambul, H. (1978). Alcoholism and treatment. New York: John Wiley and Sons.
7. Australian Institute of Health and Welfare (AIHW) (2003).Alcohol and Other Drug Treatment Services in Australia 2001-2002: Report on the National Minimum Data Set. Canberra, Australian Capital Territory: AIHW.
8. Babor, T. F., Carroll, K. M., Christiansen, K., Kadden, R., Litt, M., et al. (2004). Brief treatments for cannabis dependence: findings from a randomized multisite trial. Journal of Consulting and Clinical Psychology, 72(3), 455-466.
9. Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., Johnston, L. D., & Schulenberg, J. (1997). Smoking, drinking, and drug use in young adulthood: the impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum.
10. Beal, J., Olson, R., Lefkowitz, L., Laubenstein, L., Bellman, P., et al. (1997). Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome- associated anorexia. Journal of Pain and Symptom Management, 14, 7-14.
11. Bell, J., Ward, J., Mattick, R. P., Hay, A., Chan, J., & Hall, W. (1995). An Evaluation of Private Methadone Clinics (National Drug Strategy Research Report Series, Report No. 4). Canberra, Australian Capital Territory: Australian Government Publishing Service (AGPS).
12. Bellack, A. S., & Gearon, J. S. (1998). Substance abuse treatment for people with schizophrenia. Addictive Behaviors, 23(6), 749-766.
13. Bennett, M. E., Bellack, A. S., & Gearon, J. S. (2001). Treating substance abuse in schizophrenia: an initial report. Journal of Substance Abuse Treatment, 20(2), 163-175.
14. Bowman, J., & Sanson-Fisher, R. (1994). Public Perceptions of Cannabis Legalization, (National Drug Strategy Monograph, Vol. 28). Canberra: Australian Government Publishing Service (AGPS).
15. Budney, A. J., Radonovich, K. J., Higgins, S. T., & Wong, C. J. (1998). Adults seeking treatment for marijuana dependence: a comparison with cocaine-dependent treatment seekers. Experimental and Clinical Psychopharmacology, 6(4), 419-426.
16. Budney, A. J., Novy, P. L., & Hughes, J. R. (1999). Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction, 94(9), 1311-1322.
17. Budney, A. J., Higgins, S. T., Radonovich, K. J., & Novy, P. L. (2000). Adding voucher- based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. Journal of Consulting and Clinical Psychology, 68(6), 1051-1061.
18. Budney, A. J., Hughes, J. R., Moore, B. A., & Novy, P. L. (2001). Marijuana abstinence effects in marijuana smokers maintained in their home environment. Archives of General Psychiatry, 58(10), 917-924.
19. Calhoun, S. R., Galloway, G. P., & Smith, D. E. (1998). Abuse potential of dronabinol (Marinol). Journal of Psychoactive Drugs, 30(2), 187-196.
20. Chen, K., & Kandel, D. B. (1995). The natural history of drug use from adolescence to the mid-thirties in a general population sample. American Journal of Public Health, 85(1), 41-47.
21. Chen, K., & Kandel, D. B. (1998). Predictors of cessation of marijuana use: an event history analysis. Drug and Alcohol Dependence, 50(2), 109-121.
22. Chen, K., Kandel, D. B., & Davies, M. (1997). Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States. Drug and Alcohol Dependence, 46(1-2), 53-67.
23. Chick, J., Lloyd, G., & Crombie, E. (1985). Counselling problem drinkers in medical wards: a controlled study. British Medical Journal, 290(6473), 965-967.
24. Cohen, P., & Sas, A. (1998). Cannabis use, a stepping stone to other drugs? The case of Amsterdam. Amsterdam: Centre for Drug Research, University of Amsterdam.
25. Copeland, J., Rees, V., & Swift, W. (1999). Health concerns and help-seeking among a sample entering treatment for cannabis dependence. Australian Family Physician, 28, 540-541.
26. Copeland, J., Swift, W., & Rees, V. (2001a). Clinical profile of participants in a brief intervention program for cannabis use disorder. Journal of Substance Abuse Treatment, 20(1), 45-52.
27. Copeland, J., Swift, W., Roffman, R., & Stephens, R. (2001b). A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. Journal of Substance Abuse Treatment, 21(2), 55-64.
28. Courtwright, D. T. (2001). Forces of habit: drugs and the making of the modern world. Cambridge, MA: Harvard University Press.
29. Criminal Justice Commission (1994). Report on Cannabis and the Law in Queensland, Brisbane: Criminal Justice Commission, Queensland.
30. Darke, S., & Ross, J. (1997). Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence, 48(2), 135-141.
31. Dawes, S., & Mattick, R. (1997). Review of Diagnostic and Screening Instruments for Alcohol and Other Psychiatric Disorders (2nd ed., Monograph Series No. 48). Canberra, Australian Capital Territory: Australian Government Publishing Service (AGPS).
32. Degenhardt, L., Hall, W. D., & Lynskey, M. (2000). Cannabis Use and Mental Health among Australian Adults: Findings from the National Survey of Mental Health and Well-being (NDARC Technical Report, Vol. 98). Sydney, Australia: National Drug and Alcohol Research Centre, University of New South Wales.
33. Degenhardt, L., Hall, W., & Lynskey, M. (2001a). The relationship between cannabis use and other substance use in the general population. Drug and Alcohol Dependence, 64(3), 319-327.
34. Degenhardt, L., Hall, W., & Lynskey, M. (2001b). The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-being. Social Psychiatry and Psychiatric Epidemiology, 36(5), 219-227.
35. Dennis, M., Babor, T. F., Roebuck, M. C., & Donaldson, J. (2002). Changing the focus: the case for recognizing and treating cannabis use disorders. Addiction, 97, 4-15.
36. DeWit, D. J., Hance, J., Offord, D. R., & Ogborne, A. (2000). The influence of early and frequent use of marijuana on the risk of desistance and of progression to marijuana-related harm. Preventive Medicine, 31(5), 455-464.
37. Donnelly, N., Hall, W. D., & Christie, P. (1995). The effects of partial decriminalisation on cannabis use in South Australia, 1985 to 1993. Australian Journal of Public Health, 19(3), 281-287.
38. Donnelly, N., Hall, W. D., & Christie, P. (1999). Effects of the Cannabis Expiation Notice Scheme on Levels and Patterns of Cannabis Use in South Australia: Evidence from the National Drug Strategy Household Surveys 1985-1995 (National Drug Strategy Monograph, Vol. 37). Canberra, Australian Capital Territory: Australian Government Publishing Service (AGPS).
39. Drake, R. E., Bartels, S. J., Teague, G. B., Noordsy, D. L., & Clark, R. E. (1993). Treatment of substance abuse in severely mentally ill patients. Journal of Nervous and Mental Disease, 181(10), 606-611.
40. Dutch National Alcohol and Drug Information System (2004). Treatment demand of cannabis clients in outpatient addiction care in the Netherlands (1994-2002). LADIS Bulletin, April.
41. Edwards, G., Anderson, P., Babor, T. F., Casswell, S., Ferrence, R., et al. (1994). Alcohol policy and the public good. Oxford: Oxford University Press.
42. Elster, J. (1999). Gambling and addiction. In J. Elster, & O. Skog (Eds.), Rationality and addiction (pp. 208-234). Cambridge, MA: Cambridge University Press.
43. Elvy, G. A., Wells, J. E., & Baird, K. A. (1988). Attempted referral as intervention for problem drinking in the general hospital. British Journal of Addiction, 83(1), 83-89.
44. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2003). Annual Report 2003: The State of the Drugs Problem in the European Union and Norway. Luxembourg: Office for Official Publications of the European Communities.
45. Fergusson, D. M., Horwood, L. J., & Lynskey, M. T. (1994). Parental separation, adolescent psychopathology, and problem behaviors. Journal of the American Academy of Child and Adolescent Psychiatry, 33(8), 1122-1131; discussion 31-33.
46. Fergusson, D. M., Lynskey, M. T., & Horwood, L. J. (1996). The short-term consequences of early onset cannabis use. Journal of Abnormal Child Psychology, 24(4), 499-512.
47. Finney, J. W., Hahn, A. C., & Moos, R. H. (1996). The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects. Addiction, 91(12), 1773-1796; discussion 803-820.
48. Gieringer, D. St., Laurent, J., & Goodrich, S. (2004). Cannabis vaporizer combines efficient delivery of THC with effective suppression of pyrolytic compounds. Journal of Cannabis Therapeutics, 4, 7-27.
49. Grant, B. F. (1995). Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. Journal of Substance Abuse, 7(4), 481-497.
50. Grant, B. F. (1997). Prevalence and correlates of alcohol use and DSM-IV alcohol dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey. Journal of Studies on Alcohol, 58(5), 464-473.
51. Grinspoon, L., & Bakalar, J. (1993). Marihuana, the forbidden medicine. New Haven, CT: Yale University Press.
52. Gurley, R. J., Aranow, R., & Katz, M. (1998). Medicinal marijuana: a comprehensive review. Journal of Psychoactive Drugs, 30(2), 137-147.
53. Hafner, H., & Maurer, K. (2000). The early course of schizophrenia: new concepts for early intervention. In G. Andrews, & S. Henderson (Eds.), Unmet need in psychiatry: problems, resources, responses (pp. 318-332). Cambridge, MA: Cambridge University Press.
54. Hall, W. D. (1995a). The public health significance of cannabis use in Australia. Australian Journal of Public Health, 19(3), 235-242.
55. Hall, W. D. (1995b). The public health implications of cannabis use. Australian Journal of Public Health, 19, 235-242.
56. Hall, W. D. (1995c). What advice should family physicians give their patients about the health effects of cannabis? Australian Family Physician, 24, 1237-1242.
57. Hall, W. D. (1998). Cannabis use and psychosis. Drug and Alcohol Review, 17(4), 433-444.
58. Hall, W. D. (2000). The cannabis policy debate: finding a way forward. Canadian Medical Association Journal, 162(12), 1690-1692.
59. Hall, W. D., & Babor, T.F. (2000). Cannabis use and public health: assessing the burden. Addiction, 95(4), 485-490.
60. Hall, W. D., & Degenhardt, L. (2000). Cannabis use and psychosis: a review of clinical and epidemiological evidence. Australian and New Zealand Journal of Psychiatry, 34(1), 26-34.
61. Hall, W., & Farrell, M. (1997). Comorbidity of mental disorders with substance misuse. British Journal of Psychiatry, 171, 4-5.
62. Hall, W. D., & Pacula, R.L. (2003). Cannabis use and dependence: public health and public policy. Cambridge, MA: Cambridge University Press.
63. Hall, W. D., & Teesson, M. (2000). Alcohol use disorders: who should be treated and how? In G. Andrews, & S. Henderson (Eds.), Unmet need in psychiatry: problems, resources, responses (pp. 291-301). Cambridge, MA: Cambridge University Press.
64. Hall, W. D., & Zador, D. (1997). The alcohol withdrawal syndrome. Lancet, 349(9069), 1897-1900.
65. Hall, W. D., Teesson, M., Lynskey, M.T., & Degenhardt, L. (1999). The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well-being. Addiction, 94(10), 1541-1550.
66. Hall, W. D., Degenhardt, L., & Lynskey, M.T. (2001). The health and psychological effects of cannabis use (National Drug Strategy Monograph, Vol. 44). Canberra, Australian Capital Territory: Commonwealth Department of Health and Aged Care.
67. Heather, N., & Tebbutt, J. (1989). An overview of the effectiveness of treatment for drug and alcohol problems. (NCADA Monograph, Vol. 11). Canberra, Australian Capital Territory: Australian Government Publishing Service (AGPS).
68. Himmelstein, J. L. (1983).The strange career of marihuana: politics and ideology of drug control in America. Westport, CT: Greenwood Press.
69. Homel, R. (1990). Crime on the roads: drinking and driving. In J. Veron (Ed.), Alcohol and crime. Canberra, Australian Capital Territory: Australian Institute of Criminology.
70. Institute of Medicine (1999). Marijuana and medicine: assessing the science base. Washington, DC: National Academy Press.
71. Jablensky, A., McGrath, J., Herrman, H., Castle, D., Gureje, O., et al. (2000). Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders. Australian and New Zealand Journal of Psychiatry, 34(2), 221-236.
72. Kavanagh, D. J. (1995). An intervention for substance abuse in schizophrenia. Behaviour Change, 12(1), 20-30.
73. Kessler, R. C. (1995). Epidemiology of psychiatric comorbidity. In M. T. Tsuang, M. Tohen, & G. E. P. Zahner (Eds.), Textbook in psychiatric epidemiology (pp. 179-197). New York: Wiley and Sons.
74. Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry, 51(1), 8-19.
75. Kidorf, M., Brooner, R. K., King, V. L., Chutuape, M. A., & Stitzer, M. L. (1996). Concurrent validity of cocaine and sedative dependence diagnoses in opioid- dependent outpatients. Drug and Alcohol Dependence, 42(2), 117-123.
76. Kristenson, H., Ohlin, H., Hulten-Nosslin, M. B., Trell, E., & Hood, B. (1983). Identification and intervention of heavy drinking in middle-aged men: results and follow-up of 24-60 months of long-term study with randomized controls. Alcoholism, Clinical and Experimental Research, 7(2), 203-209.
77. Krystal, J. H., D’Souza, D. C., Madonick, S., & Petrakis, I. L. (1999). Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients. Schizophrenia Research, 35 (Suppl.), S35-S49.
78. Lynskey, M., & Hall, W. (2000). Educational outcomes and adolescent cannabis use. Sydney: New South Wales Department of Education and Training.
79. Lynskey, M. T., Heath, A. C., Bucholz, K. K., & Slutske, W. S. (2003). Escalation of drug use in early-onset cannabis users vs. co-twin controls. Journal of the American Medical Association, 289(4), 427-433.
80. MacCoun, R., & Reuter, P. (1997). Interpreting Dutch cannabis policy: reasoning by analogy in the legalization debate. Science, 278(5335), 47-52.
81. MacCoun, R., & Reuter, P. (2000). Beyond the drug war: Learning from other vices, other time. Cambridge, MA: Cambridge University Press.
82. MacCoun, R., & Reuter, P. (2001). Drugwar heresies: learning from other vices, times and places. Cambridge, MA: Cambridge University Press.
83. Maloff, D. (1981). A review of the effects of the decriminalization of marijuana. Contemporary Drug Problems, 10, 307-322.
84. Maurer, M., Henn, V., Dittrich, A., & Hofmann, A. (1990). Delta-9-tetrahydrocannabi- nol shows antispastic and analgesic effects in a single case double-blind trial. European Archives of Psychiatry and Clinical Neuroscience, 240(1), 1-4.
85. McCambridge, J., & Strang, J. (2004). The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction, 99(1), 39-52.
86. McLellan, A. T., Luborsky, L., Woody, G. E., O’Brien, C. P., & Druley, K. A. (1983). Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Archives of General Psychiatry, 40(6), 620-625.
87. Miller, W. R., & Sovereign, R. G. (1989). The check-up: a model for early intervention in addictive behaviors. In T. Leberg, W. Miller, G. Nathan, & G. Marlatt (Eds.), Addictive behaviors: prevention and early intervention (pp. 219-231). Amsterdam: Swets and Zeitlinger.
88. Mueser, K. T., Bellack, A. S., & Blanchard, J. J. (1992). Comorbidity of schizophrenia and substance abuse: implications for treatment. Journal of Consulting and Clinical Psychology, 60(6), 845-856.
89. Nahas, G., & Latour, C. (1992). The human toxicity of marijuana. Medical Journal of Australia, 156(7), 495-497.
90. Neff, G. W., O’Brien, C. B., Reddy, K. R., Bergasa, N. V., Regev, A., et al. (2002). Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease. American Journal of Gastroenterology, 97(8), 2117-2119.
91. New South Wales Department of Education and Training (2003). Cannabis: Know the Risks (interactive educational material). Sydney: New South Wales (NSW) Department of Education and Training.
92. Orford, J., & Edwards, G. (1977).Alcoholism: a comparison of treatment and advice, with a study of the influence of marriage. Oxford: Oxford University Press.
93. Peek-Asa, C. (1999). The effect of random alcohol screening in reducing motor vehicle crash injuries. American Journal of Preventive Medicine, 16(Suppl. 1), 57-67.
94. Penrose-Wall, J., Copeland, J., & Harris, M. (2000). Shared Care of Illicit Drug Problems by General Practitioners and Primary Health Care Providers: A Literature Review. Sydney: Centre for General Practice Integration Studies, University of New South Wales.
95. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., et al. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association, 264(19), 2511-2518.
96. Regier, D. A., Narrow, W. E., Rae, D. S., Manderscheid, R. W., Locke, B. Z., et al. (1993). The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry, 50(2), 85-94.
97. Robins, L., Darvish, H. S., & Murphy, G. E. (1970). The long-term outcome for adolescent drug users: a follow-up study of 76 users and 146 nonusers. In J. Zubin and A. M. Freedman (Eds.), The psychopathology of adolescence. New York: Grune and Stratton.
98. Roche, A.M., & Freeman, T. (2004). Brief interventions: good in theory but weak in practice. Drug and Alcohol Review, 23(1), 11-18.
99. Sas, A., & Cohen, P. (1997).Patterns of Cannabis Use in Amsterdam Among Experienced Cannabis Users: some Preliminary Data from the 1995 Amsterdam Cannabis Survey. Amsterdam: Centrum voor Drugsonderzoek, Universiteit van Amsterdam.
100. Shand, F., & Mattick, R. (2001). Clients of Treatment Service Agencies: May 2001 Census Findings (National Drug Strategy Monograph, Vol. 47). Canberra, Australian Capital Territory: Commonwealth Department of Health and Ageing.
101. Shand, F., Gates, J., Fawcett, J., & Mattick, R. (2003). The treatment of alcohol problems: a review of the evidence. Canberra, Australian Capital Territory: Commonwealth Department of Health and Ageing.
102. Single, E., Christie, P., & Ali, R. (1999). The Impact of Cannabis Decriminalization in Australia and the United States. Adelaide, Australia: Drug and Alcohol Services Council.
103. Single, E.W. (1989). The impact of marijuana decriminalization: an update. Journal of Public Health Policy, 9(4), 456-466.
104. Stephens, R. S., Roffman, R. A., & Simpson, E. E. (1994). Treating adult marijuana dependence - a test of the relapse prevention model. Journal of Consulting and Clinical Psychology, 62(1), 92-99.
105. Stephens, R. S., Roffman, R. A., & Curtin, L. (2000). Comparison of extended versus brief treatments for marijuana use. Journal of Consulting and Clinical Psychology, 68(5), 898-908.
106. Stephens, R. S., Babor, T. F., Kadden, R., & Miller, M. (2002). The Marijuana Treatment Project: rationale, design and participant characteristics. Addiction, 97, 109-124.
107. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies (2004). Treatment Episode Data Set (TEDS). Highlights - 2002. National Admissions to Substance Abuse Treatment Services, DAIS Series: S-22, DHHS Publication No. (SMA) 04-3946, Rockville, MD: Office of Applied Studies.
108. Swift, W., & Hall, W. (2002). Dependence. In F. Grotenhermen (Ed.), Cannabis and cannabinoids: pharmacology, toxicology and therapeutic potential (pp. 257-268). New York: Springer-Verlag.
109. Swift, W., Hall, W. D., & Copeland, J. (1998a). Characteristics of long-term cannabis users in Sydney, Australia. European Addiction Research, 4(4), 190-197.
110. Swift, W., Hall, W. D., Didcott, P., & Reilly, D. (1998b). Patterns and correlates of cannabis dependence among long-term users in an Australian rural area. Addiction, 93(8), 1149-1160.
111. Swift, W., Copeland, J., & Lenton, S. (2000). Cannabis harm reduction. Drug and Alcohol Review, 19(1), 101-112.
112. Swift, W., Hall, W., & Teesson, M. (2001a). Cannabis use and dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing. Addiction, 96(5), 737-748.
113. Swift, W., Hall, W. D., & Teesson, C. (2001b). Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Well-being. Drug and Alcohol Dependence, 63(2), 147-153.
114. Wallace, P., Cutler, S., & Haines, A. (1988). Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. British Medical Journal, 297(6649), 663-668.
115. Walsh, D., & Hingson, R. (1987). Epidemiology and alcohol policy. In S. Levine, & A. Lilienfeld (Eds.), Epidemiology and public policy (pp. 265-291). New York: Tavistock.
116. Webster, P., Mattick, R., & Baillie, A. (1991). Clients of Treatment Service Agencies: March 1990 Census Findings. Canberra, Australian Capital Territory: Australian Government Publishing Service Government Publishing Service (AGPS).
117. Ziedonis, D., & Brady, K. (1997). Dual diagnosis in primary care. Detecting and treating both the addiction and mental illness. Medical Clinics of North America, 81(4), 1017-1036.
118. Zimmer, L., & Morgan, J. P. (1997).Marijuana myths, marijuana facts: a review of the scientific evidence.New York: The Lindesmith Center.